# Liraglutide and Heart Failure in Type 2 Diabetes

> **NCT01425580** · PHASE2 · COMPLETED · sponsor: **Thomas Nystrom** · enrollment: 62 (actual)

## Conditions studied

- Congestive Heart Failure
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** liraglutide
- **DRUG:** glimepiride
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01425580
- **Lead sponsor:** Thomas Nystrom
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2016-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01425580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01425580, "Liraglutide and Heart Failure in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01425580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*